NDC 50090-5960-01 - Losartan Potassium and Hydrochlorothiazide
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 50090-5960
- Requested NDC
- 50090-5960-01
- Package NDCs from labels
- 50090-5960-0, 50090-5960-2, 50090-5960-1, 50090-5960-01
- Manufacturer
- A-S Medication Solutions
- Effective date
- 2024-05-06
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Losartan Potassium and Hydrochlorothiazide - A-S Medication Solutions | A-S Medication Solutions | 2024-05-06 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 50090-5960-0 | Losartan Potassium and Hydrochlorothiazide | 30 in 1 BOTTLE | TABLET, FILM COATED | 30 | 7 | |
| 50090-5960-1 | Losartan Potassium and Hydrochlorothiazide | 90 in 1 BOTTLE | TABLET, FILM COATED | 90 | 7 | |
| 50090-5960-2 | Losartan Potassium and Hydrochlorothiazide | 100 in 1 BOTTLE | TABLET, FILM COATED | 100 | 7 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 50090-5960 | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE (LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE) TABLET, FILM COATED [A-S MEDICATION SOLUTIONS] | 7 | Current NDC, Legacy NDC, 3 package rows | 20240511_1bb08103-04ee-47a6-a9ad-290e169feb51.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 50090-5960-0 | EA - Each | 50090-5960 | 236055f1-416d-4476-9b0a-73e1e0487b4e | 1 | 2022-07-06 |
| 50090-5960-1 | EA - Each | 50090-5960 | 7d68ca49-dafa-447b-a05c-8d0bc0a3e141 | 1 | 2022-07-06 |
| 50090-5960-2 | EA - Each | 50090-5960 | 4e10ae2d-dd32-475b-9ed6-a7938f3dac25 | 1 | 2023-04-07 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| JUNGSAEMMOOL Essential Skin Nuder Longwear Cushion Light | TITANIUM DIOXIDE, OCTINOXATE, ZINC OXIDE, OCTISALATE | Jungsaemmool Beauty Co., Ltd. | e98696d2-7f7f-4a4c-b8ae-849f2d211a04 | 2024-08-04 | Warnings | 15FIX9V2JP |
| JUNGSAEMMOOL Essential Skin Nuder Longwear Cushion Medium Deep | TITANIUM DIOXIDE, OCTINOXATE, ZINC OXIDE, OCTISALATE | Jungsaemmool Beauty Co., Ltd. | f31842f7-3474-4462-87e2-c4ebde97a583 | 2024-08-04 | Warnings | 15FIX9V2JP |
| JUNGSAEMMOOL Essential Skin Nuder Longwear Cushion Medium | TITANIUM DIOXIDE, OCTINOXATE, ZINC OXIDE, OCTISALATE | Jungsaemmool Beauty Co., Ltd. | ccfafefc-fff4-41ff-baf4-3f430c690be7 | 2024-08-04 | Warnings | 15FIX9V2JP |
| Losartan Potassium | LOSARTAN POTASSIUM | Proficient Rx LP | 4b298291-4251-4af8-a436-58a3443a7978 | 2024-08-01 | Boxed warning, Warnings, Adverse reactions | 3ST302B24A |
| Essential Sheer SPF 50 | ZINC OXIDE TITANIUM DIOXIDE | Topiderm, Inc. | 2132dc18-85ee-4449-86d2-d9f698f286c6 | 2024-07-31 | Warnings | 15FIX9V2JP |
| Olmesartan Medoxomil and Hydrochlorothiazide | OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE | A-S Medication Solutions | b78ad43f-f132-4f03-8c85-2cf9b3ab555b | 2024-07-30 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Proceuticals Private Label by TiZO tinted foaming mineral sunscreen | TITANIUM DIOXIDE, ZINC OXIDE | Fallien Cosmeceuticals, Ltd | 1e78109f-4d2e-2705-e063-6294a90a5ad3 | 2024-07-30 | Warnings | 15FIX9V2JP |
| Replenix Sheer SPF 50 | ZINC OXIDE TITANIUM DIOXIDE | Topiderm, Inc. | 37d1f454-3bc9-4ce5-863c-0d4f6fa18fb4 | 2024-07-29 | Warnings | 15FIX9V2JP |
| HYDROCHLOROTHIAZIDE | HYDROCHLOROTHIAZIDE | NuCare Pharmaceuticals,Inc. | 1e02787f-ccb5-abc2-e063-6294a90af7c3 | 2024-07-24 | Warnings, Adverse reactions | 0J48LPH2TH |
| Lisinopril and Hydrochlorothiazide | LISINOPRIL AND HYDROCHLOROTHIAZIDE | NuCare Pharmaceuticals, Inc. | 4af326db-bf2d-5310-e054-00144ff88e88 | 2024-07-19 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Lisinopril and Hydrochlorothiazide | LISINOPRIL AND HYDROCHLOROTHIAZIDE | NuCare Pharmaceuticals,Inc. | 7cc69c16-0dcc-874d-e053-2991aa0a9919 | 2024-07-17 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| LOSARTAN POTASSIUM 100 mg | LOSARTAN POTASSIUM | NuCare Pharmaceuticals,Inc. | a955160f-3c2d-3366-e053-2a95a90a65ea | 2024-07-17 | Boxed warning, Warnings, Adverse reactions | 3ST302B24A |
| Losartan Potassium | LOSARTAN POTASSIUM | NuCare Pharmaceuticals,Inc. | aa58c629-f7d9-a6e0-e053-2995a90ac188 | 2024-07-17 | Boxed warning, Warnings, Adverse reactions | 3ST302B24A |
| Lisinopril and Hydrochlorothiazide | LISINOPRIL AND HYDROCHLOROTHIAZIDE TABLETS | NuCare Pharmaceuticals,Inc. | af74c331-7402-408c-e053-2a95a90a1043 | 2024-07-17 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Lisinopril and Hydrochlorothiazide | LISINOPRIL AND HYDROCHLOROTHIAZIDE TABLETS | NuCare Pharmaceuticals,Inc. | b2e8b3bb-0ab5-ffd7-e053-2995a90aa2b6 | 2024-07-17 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Lisinopril and Hydrochlorothiazide | LISINOPRIL AND HYDROCHLOROTHIAZIDE TABLETS | NuCare Pharmaceuticals,Inc. | b4c9abf7-a2c6-7042-e053-2a95a90a7653 | 2024-07-17 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Lisinopril and hydrochlorothiazide | LISINOPRIL AND HYDROCHLOROTHIAZIDE | NuCarePharmaceuticals, Inc. | 4fbf31a1-037b-31a2-e054-00144ff88e88 | 2024-07-17 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Losartan Potassium | LOSARTAN POTASSIUM | NuCare Pharmaceuticals,iNc. | 54b363c4-00bb-08db-e054-00144ff8d46c | 2024-07-17 | Boxed warning, Warnings, Adverse reactions | 3ST302B24A |
| Derma E Sun Defense Face SPF 30 | ZINC OXIDE TITANIUM DIOXIDE | derma e | d90b8f81-de7a-4022-800a-90f063e94180 | 2024-07-17 | Warnings | 15FIX9V2JP |
| Triamterene and Hydrochlorothiazide | TRIAMTERENE AND HYDROCHLOROTHIAZIDE | NuCare Pharmaceuticals,Inc. | 7c214ebf-e0ed-6538-e053-2991aa0a8079 | 2024-07-16 | Warnings, Adverse reactions | 0J48LPH2TH |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.